Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NX2G
|
|||
Former ID |
DNC012200
|
|||
Drug Name |
(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine
|
|||
Synonyms |
CHEMBL284485; (1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine; SCHEMBL8561085; BDBM50099965
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H17N5
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)NC4=NC=NC5=CC=CC=C54)C=N2
|
|||
InChI |
1S/C22H17N5/c1-2-6-16(7-3-1)14-27-21-11-10-18(12-17(21)13-25-27)26-22-19-8-4-5-9-20(19)23-15-24-22/h1-13,15H,14H2,(H,23,24,26)
|
|||
InChIKey |
FIBNGENIDQNCFP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2. Bioorg Med Chem Lett. 2001 Jun 4;11(11):1401-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.